PONCIANO D CRUZ, MD
Dermatology at Harry Hines Blvd, Dallas, TX
License number
Texas G7632
Category
Osteopathic Medicine
Type
Dermatology
Address
Address
5323 Harry Hines Blvd, Dallas, TX 75390
Phone
(214) 645-2400
Personal information
See more information about PONCIANO D CRUZ at radaris.comName
Address
Phone
2011 Cedar Springs Rd APT 607, Dallas, TX 75201
6263 Harry Hines Blvd, Dallas, TX 75235
5323 Harry Hines Blvd, Dallas, TX 75390
9550 Long Point Rd, Houston, TX 77055
1855 Wirt Rd, Houston, TX 77055
Professional information
Ponciano D Cruz, Dallas TX
Specialties:
Dermatologist
Address:
5323 Harry Hines Blvd, Dallas, TX 75390
Education:
University of the Philippines, College of Medicine (Manila) - Doctor of Medicine
Parkland Memorial Hospital - Fellowship - Dermatology
Parkland Memorial Hospital - Residency - Dermatology
Kettering Medical Center - Residency - Internal Medicine
Parkland Memorial Hospital - Fellowship - Dermatology
Parkland Memorial Hospital - Residency - Dermatology
Kettering Medical Center - Residency - Internal Medicine
Board certifications:
American Board of Dermatology Certification in Dermatology, American Board of Dermatology Sub-certificate in Dermatological Immunology/Diagnostic & Laboratory Immunology (Dermatology), American Board of Internal Medicine Certification in Internal Medicine
Dr. Ponciano D Cruz, Dallas TX - MD (Doctor of Medicine)
Specialties:
Diagnostic Laboratory & Dermatologic Immunology
Address:
Dallas
5323 Harry Hines Blvd, Dallas 75390
(214) 648-3111 (Phone), (214) 648-2961 (Fax)
University Tx Sthwt Unv Hsp Drm
5939 Harry Hines Blvd, Dallas 75235
(214) 645-2400 (Phone)
Dallas
5323 Harry Hines Blvd, Dallas 75390
(214) 648-3111 (Phone), (214) 645-0078 (Fax)
5323 Harry Hines Blvd, Dallas 75390
(214) 648-3111 (Phone), (214) 648-2961 (Fax)
University Tx Sthwt Unv Hsp Drm
5939 Harry Hines Blvd, Dallas 75235
(214) 645-2400 (Phone)
Dallas
5323 Harry Hines Blvd, Dallas 75390
(214) 648-3111 (Phone), (214) 645-0078 (Fax)
Certifications:
Dermatology, 1988, Diagnostic Laboratory & Dermatological Immunology, 1989, Internal Medicine, 1984
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
Dallas
5323 Harry Hines Blvd, Dallas 75390
Dallas
5323 Harry Hines Blvd, Dallas 75390
University Tx Sthwt Unv Hsp Drm
5939 Harry Hines Blvd, Dallas 75235
Parkland Health and Hospital System
5201 Harry Hines Blvd, Dallas 75235
Ut Southwestern University Hospital
5909 Harry Hines Blvd, Dallas 75390
5323 Harry Hines Blvd, Dallas 75390
Dallas
5323 Harry Hines Blvd, Dallas 75390
University Tx Sthwt Unv Hsp Drm
5939 Harry Hines Blvd, Dallas 75235
Parkland Health and Hospital System
5201 Harry Hines Blvd, Dallas 75235
Ut Southwestern University Hospital
5909 Harry Hines Blvd, Dallas 75390
Education:
Medical School
UNIVERSITY OF THE PHILIPPINES / COLLEGE OF MEDICINE
Kettering Med Ctr
Parkland Memorial Hospital
UNIVERSITY OF THE PHILIPPINES / COLLEGE OF MEDICINE
Kettering Med Ctr
Parkland Memorial Hospital
Ponciano Cruz, Dallas TX
Specialties:
Dermatology, Dermatological Immunology/Diagnostic and Laboratory Immunology, Internal Medicine, Allergy
Work:
Va North Texas Health Care System: Dallas Va Medical Center
4500 S Lancaster Rd, Dallas, TX 75216
4500 S Lancaster Rd, Dallas, TX 75216
Education:
University Of The Philippines Manila (1979)
Dc-Hil Conjugates For Treatment Of T-Cell Disorders
US Patent:
2009029, Dec 3, 2009
Filed:
Mar 26, 2009
Appl. No.:
12/411898
Inventors:
Kiyoshi Ariizumi - Dallas TX, US
Ponciano D. Cruz - Dallas TX, US
Ponciano D. Cruz - Dallas TX, US
International Classification:
A61K 38/21, A61K 39/395, C12N 9/00, C07K 19/00
US Classification:
424 857, 4241731, 4241781, 4241831, 435183, 5303917
Abstract:
The present invention relates to the use of DC-HIL and fragments and variants thereof to selectively target toxins to activated T-cells expressing a unique form of syndecan-4 that is not found on other cells. Thus, the toxin is delivered only to activated T-cells, and not to other syndecan-4 expressing cells. Such toxin-DC-HIL conjugates are useful in the treatment of T-cell inflammatory disorders such as dermatitis, autoimmune disease, and graft rejection, as well as T-cell lymphomas.
Keptin-A Novel Keratinocyte-Specific Proteinase Inhibitor
US Patent:
2003021, Nov 13, 2003
Filed:
May 7, 2002
Appl. No.:
10/141530
Inventors:
Kiyoshi Ariizumi - Plano TX, US
Ponciano Cruz - Dallas TX, US
Ponciano Cruz - Dallas TX, US
Assignee:
Board of Regents, The University of Texas System
International Classification:
C07H021/04, C12N009/99, A61K038/57, C12P021/02, C12N005/06, C07K016/40
US Classification:
435/184000, 435/069200, 435/320100, 435/325000, 514/012000, 536/023200, 530/388260, 435/338000
Abstract:
The present invention provides a novel keratinocyte-specific secreted protein identified as keptin that inhibits an inflammatory response and activity of proteinase, as well as methods for treating hyperproliferative inflammatory skin diseases using proteinase inhibitor keptin. The invention provides a therapeutic agent for treating psoriasis and squamous cell carcinomas and other inflammatory skin related diseases.